Chronic ischemic left ventricular dysfunction is present in a number of clinical syndromes in which myocardial revascularization results in an improvement of left ventricular function, patients' functional class, and their survival. Early diagnosis of and treatment of viability is essential. Coronary arteriography is of limited value in diagnosis of viability. Noninvasive testing is essential for diagnosis, which can be matched to the pathophysiologic changes that occur in hibernating myocardium. However, no single test has a perfect, or near perfect, sensitivity and specificity, and thus, a combination of tests are usually needed. Algorithms are developed to integrate these tests in clinical decision making
Coronary artery disease (CAD) is the most prevalent and single most common cause of morbidity and mo...
Preserved myocardial viability and recurrent symptomatic ischemia are the most widely accepted crite...
The differentiation of viable from nonviable myocardium in patients with myocardial infarction (MI) ...
Chronic ischemic left ventricular dysfunction is present in a number of clinical syndromes in which ...
Chronic ischemic left ventricular dysfunction is present in a number of clinical syndromes in which ...
Chronic ischemic left ventricular dysfunction is present in a number of clinical syndromes in which ...
Patients with chronic ischemic left ventricular dysfunction may have a substantial amount of viable,...
There is growing interest in the assessment of myocardial viability in patients with ischaemic left ...
Ischaemic left ventricular (LV) dysfunction can arise from myocardial stunning, hibernation, or necr...
Chronic ischemic left ventricular dysfunction is present in number of clinical syndromes in which my...
textabstractIschemic heart disease is the leading cause of morbidity and mortality in the western wo...
BackgroundThe assessment of myocardial viability has become an integrated part in the diagnosis of p...
Nuclear imaging procedures are well-established diagnostic tools in clinical cardiology, providing n...
Coronary artery disease (CAD) is the most prevalent and single most common cause of morbidity and mo...
The severity of myocardial ischemia cannot always be predicted by coronary arteriography alone. The ...
Coronary artery disease (CAD) is the most prevalent and single most common cause of morbidity and mo...
Preserved myocardial viability and recurrent symptomatic ischemia are the most widely accepted crite...
The differentiation of viable from nonviable myocardium in patients with myocardial infarction (MI) ...
Chronic ischemic left ventricular dysfunction is present in a number of clinical syndromes in which ...
Chronic ischemic left ventricular dysfunction is present in a number of clinical syndromes in which ...
Chronic ischemic left ventricular dysfunction is present in a number of clinical syndromes in which ...
Patients with chronic ischemic left ventricular dysfunction may have a substantial amount of viable,...
There is growing interest in the assessment of myocardial viability in patients with ischaemic left ...
Ischaemic left ventricular (LV) dysfunction can arise from myocardial stunning, hibernation, or necr...
Chronic ischemic left ventricular dysfunction is present in number of clinical syndromes in which my...
textabstractIschemic heart disease is the leading cause of morbidity and mortality in the western wo...
BackgroundThe assessment of myocardial viability has become an integrated part in the diagnosis of p...
Nuclear imaging procedures are well-established diagnostic tools in clinical cardiology, providing n...
Coronary artery disease (CAD) is the most prevalent and single most common cause of morbidity and mo...
The severity of myocardial ischemia cannot always be predicted by coronary arteriography alone. The ...
Coronary artery disease (CAD) is the most prevalent and single most common cause of morbidity and mo...
Preserved myocardial viability and recurrent symptomatic ischemia are the most widely accepted crite...
The differentiation of viable from nonviable myocardium in patients with myocardial infarction (MI) ...